Abstract
The maintenance and assembly of chromatin is critical for the health of all cells. Cells, whether dividing or quiescent, that propagate damaged DNA or maintain chromosomes that are not properly assembled and/or packaged will ultimately succumb to genomic instability and cell death. Chromatin, the building block of the chromosome, is composed of repeated units of 147 basepairs of DNA wrapped around two copies of each of the four core histones, H2A, H2B, H3 and H4. Histones within chromatin serve as templates for a host of posttranslational modifications that facilitate virtually all events that require chromatin or chromosomes. Many studies have focused on the molecular mechanisms mediating and regulating the assembly process. These studies have utilized model systems ranging from yeast to humans. The regulatory processes are tightly linked to the cell cycle and require precise interactions between kinase cascades and the ubiquitintargeting pathway. It appears likely that not only are the series of factors required to assemble chromatin conserved across evolutionary boundaries, but so are the regulatory mechanisms that control these processes. The implications of these findings to research make it clear that lower eukaryotic model systems provide a powerful opportunity to learn valuable lessons about complicated higher eukaryotic molecular pathways. The lessons learned from yeast studies will provide valuable insight into understanding the disease processes that occur in humans as a result of impaired chromatin assembly.
Keywords: chromatin assembly, caf-I, anaphase promoting complex, mitosis, evolutionary conservation
Current Genomics
Title: Chromatin Assembly from Yeast to Man: Conserved Factors and Conserved Molecular Mechanisms
Volume: 6 Issue: 4
Author(s): Troy A.A. Harkness
Affiliation:
Keywords: chromatin assembly, caf-I, anaphase promoting complex, mitosis, evolutionary conservation
Abstract: The maintenance and assembly of chromatin is critical for the health of all cells. Cells, whether dividing or quiescent, that propagate damaged DNA or maintain chromosomes that are not properly assembled and/or packaged will ultimately succumb to genomic instability and cell death. Chromatin, the building block of the chromosome, is composed of repeated units of 147 basepairs of DNA wrapped around two copies of each of the four core histones, H2A, H2B, H3 and H4. Histones within chromatin serve as templates for a host of posttranslational modifications that facilitate virtually all events that require chromatin or chromosomes. Many studies have focused on the molecular mechanisms mediating and regulating the assembly process. These studies have utilized model systems ranging from yeast to humans. The regulatory processes are tightly linked to the cell cycle and require precise interactions between kinase cascades and the ubiquitintargeting pathway. It appears likely that not only are the series of factors required to assemble chromatin conserved across evolutionary boundaries, but so are the regulatory mechanisms that control these processes. The implications of these findings to research make it clear that lower eukaryotic model systems provide a powerful opportunity to learn valuable lessons about complicated higher eukaryotic molecular pathways. The lessons learned from yeast studies will provide valuable insight into understanding the disease processes that occur in humans as a result of impaired chromatin assembly.
Export Options
About this article
Cite this article as:
Harkness A.A. Troy, Chromatin Assembly from Yeast to Man: Conserved Factors and Conserved Molecular Mechanisms, Current Genomics 2005; 6 (4) . https://dx.doi.org/10.2174/1389202054395937
DOI https://dx.doi.org/10.2174/1389202054395937 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNA: Biogenesis, Function and Role in Cancer
Current Genomics Genetic Predisposition to Neonatal Tumors
Current Pediatric Reviews Gene Therapy for Pituitary Tumors
Current Gene Therapy Branched-Chain Amino Acids and Pigment Epithelium-Derived Factor: Novel Therapeutic Agents for Hepatitis C Virus-Associated Insulin Resistance
Current Medicinal Chemistry SENP1 as A Biomarker for the Diagnosis of Cancer: Review of the Science and Published Patents
Recent Patents on Biomarkers Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review
Anti-Cancer Agents in Medicinal Chemistry Nutrient Regulation of Tumor and Vascular Endothelial Cell Proliferation
Current Cancer Drug Targets Activation of Myosin Phosphatase by Epigallocatechin-Gallate Sensitizes THP-1 Leukemic Cells to Daunorubicin
Anti-Cancer Agents in Medicinal Chemistry Rb Function in the Apoptosis and Senescence of Non-Neuronal and Neuronal Cells: Role in Oncogenesis
Current Molecular Medicine Molecular Mechanism of Anti-tumor Effect by Triptolide in Hematological Malignancies
Current Signal Transduction Therapy Nano-pharmaceutical Formulations for Targeted Drug Delivery against HER2 in Breast Cancer
Current Cancer Drug Targets MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design Peptide Aptamers: Specific Inhibitors of Protein Function
Current Molecular Medicine Machine Learning for Childhood Acute Lymphoblastic Leukaemia Gene Expression Data Analysis: A Review
Current Bioinformatics PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
Current Cancer Drug Targets Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development
Current Pharmaceutical Design Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation
Current Pharmacogenomics and Personalized Medicine Sirtuin Family: A Link to Metabolic Signaling and Senescence
Current Medicinal Chemistry Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms
Current Pharmaceutical Design